ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Ecto
About
Ecto is a digital biology company developing technology to make protein production more efficient and sustainable
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $7M
- Industries
- Aquaculture,Biotechnology,Health Diagnostics,Information Technology
- Founded date
- Nov 18, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Ecto develops technology at the intersection of data and biology to enable a more efficient and sustainable aquaculture industry. They collaborate with farmers to streamline production and health management by leveraging advanced molecular tools and digital technologies. To date, Ecto's solutions have enabled farmers to create 51,510,714 additional healthy servings of protein.Ecto has offices in Boston, Atlanta, and Stavanger Norway, and serves customers all over the world. The company was founded at Harvard Innovation Labs in 2013 by Dmitry Kozachenok and James Webb. The company has received competitive research grants from the US National Science Foundation, US Department of Agriculture, and Innovation Norway.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2021 | Series A | $7M | 1 | — | — | Detail |
| Jun 21, 2019 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Oct 26, 2017 | Series Unknown | $5.48M | 1 |
Aqua Spark
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
Aqua Spark
|
— | Series A |
